Annual SGA
$294.51 M
+$24.76 M+9.18%
December 31, 2024
Summary
- As of March 6, 2025, ORGO annual SGA is $294.51 million, with the most recent change of +$24.76 million (+9.18%) on December 31, 2024.
- During the last 3 years, ORGO annual SGA has risen by +$44.31 million (+17.71%).
- ORGO annual SGA is now at all-time high.
Performance
ORGO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$73.86 M
+$2.06 M+2.87%
December 31, 2024
Summary
- As of March 6, 2025, ORGO quarterly SGA is $73.86 million, with the most recent change of +$2.06 million (+2.87%) on December 31, 2024.
- Over the past year, ORGO quarterly SGA has increased by +$12.47 million (+20.32%).
- ORGO quarterly SGA is now -6.90% below its all-time high of $79.33 million, reached on September 30, 2022.
Performance
ORGO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$191.08 M
+$861.00 K+0.45%
December 31, 2024
Summary
- As of March 6, 2025, ORGO TTM SGA is -$191.08 million, with the most recent change of +$861.00 thousand (+0.45%) on December 31, 2024.
- Over the past year, ORGO TTM SGA has dropped by -$460.83 million (-170.83%).
- ORGO TTM SGA is now -463681.55% below its all-time high of -$41.20 thousand.
Performance
ORGO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ORGO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.2% | +20.3% | -170.8% |
| 3 y3 years | +17.7% | +20.3% | -170.8% |
| 5 y5 years | +47.2% | +26.8% | -191.2% |
ORGO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.7% | -6.9% | +20.3% | -13.7% | +55.9% |
| 5 y | 5-year | at high | +47.2% | -6.9% | +58.8% | -13.7% | +73.5% |
| alltime | all time | at high | +216.6% | -6.9% | +95.7% | <-9999.0% | +73.5% |
Organogenesis Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $294.51 M(+9.2%) | $73.86 M(+2.9%) | $294.51 M(+4.4%) |
| Sep 2024 | - | $71.80 M(-6.2%) | $282.04 M(+2.8%) |
| Jun 2024 | - | $76.54 M(+5.8%) | $274.46 M(+2.3%) |
| Mar 2024 | - | $72.32 M(+17.8%) | $268.24 M(-0.6%) |
| Dec 2023 | $269.75 M(-5.0%) | $61.38 M(-4.4%) | $269.75 M(-2.5%) |
| Sep 2023 | - | $64.22 M(-8.7%) | $276.67 M(-5.2%) |
| Jun 2023 | - | $70.32 M(-4.8%) | $291.77 M(-0.8%) |
| Mar 2023 | - | $73.83 M(+8.1%) | $294.06 M(+3.6%) |
| Dec 2022 | $283.81 M(+13.4%) | $68.29 M(-13.9%) | $283.81 M(+0.4%) |
| Sep 2022 | - | $79.33 M(+9.3%) | $282.76 M(+6.4%) |
| Jun 2022 | - | $72.61 M(+14.2%) | $265.81 M(+4.0%) |
| Mar 2022 | - | $63.58 M(-5.5%) | $255.55 M(+2.1%) |
| Dec 2021 | $250.20 M | $67.25 M(+7.8%) | $250.20 M(+5.9%) |
| Sep 2021 | - | $62.37 M(+0.0%) | $236.35 M(+4.9%) |
| Jun 2021 | - | $62.35 M(+7.1%) | $225.30 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $58.23 M(+9.1%) | $209.46 M(+2.8%) |
| Dec 2020 | $204.19 M(+2.1%) | $53.40 M(+4.0%) | $203.84 M(+0.3%) |
| Sep 2020 | - | $51.33 M(+10.4%) | $203.20 M(+0.9%) |
| Jun 2020 | - | $46.50 M(-11.6%) | $201.35 M(-1.2%) |
| Mar 2020 | - | $52.61 M(-0.3%) | $203.81 M(+1.9%) |
| Dec 2019 | $200.09 M(+23.5%) | $52.76 M(+6.6%) | $200.09 M(+2.7%) |
| Sep 2019 | - | $49.48 M(+1.1%) | $194.80 M(+5.9%) |
| Jun 2019 | - | $48.96 M(+0.1%) | $183.91 M(+6.5%) |
| Mar 2019 | - | $48.89 M(+3.0%) | $172.69 M(+6.6%) |
| Dec 2018 | $161.96 M(+21.1%) | $47.48 M(+23.1%) | $161.96 M(+41.5%) |
| Sep 2018 | - | $38.58 M(+2.2%) | $114.48 M(+50.8%) |
| Jun 2018 | - | $37.73 M(-1.1%) | $75.90 M(+98.9%) |
| Mar 2018 | - | $38.16 M | $38.16 M |
| Dec 2017 | $133.72 M(+43.7%) | - | - |
| Dec 2016 | $93.03 M | - | - |
FAQ
- What is Organogenesis Holdings annual SGA?
- What is the all time high annual SGA for Organogenesis Holdings?
- What is Organogenesis Holdings annual SGA year-on-year change?
- What is Organogenesis Holdings quarterly SGA?
- What is the all time high quarterly SGA for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly SGA year-on-year change?
- What is Organogenesis Holdings TTM SGA?
- What is the all time high TTM SGA for Organogenesis Holdings?
- What is Organogenesis Holdings TTM SGA year-on-year change?
What is Organogenesis Holdings annual SGA?
The current annual SGA of ORGO is $294.51 M
What is the all time high annual SGA for Organogenesis Holdings?
Organogenesis Holdings all-time high annual SGA is $294.51 M
What is Organogenesis Holdings annual SGA year-on-year change?
Over the past year, ORGO annual SGA has changed by +$24.76 M (+9.18%)
What is Organogenesis Holdings quarterly SGA?
The current quarterly SGA of ORGO is $73.86 M
What is the all time high quarterly SGA for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly SGA is $79.33 M
What is Organogenesis Holdings quarterly SGA year-on-year change?
Over the past year, ORGO quarterly SGA has changed by +$12.47 M (+20.32%)
What is Organogenesis Holdings TTM SGA?
The current TTM SGA of ORGO is -$191.08 M
What is the all time high TTM SGA for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM SGA is -$41.20 K
What is Organogenesis Holdings TTM SGA year-on-year change?
Over the past year, ORGO TTM SGA has changed by -$460.83 M (-170.83%)